文献速递冠心病

区分2型心肌梗死患者的临床预测评分

Discrimination of patients with type 2 myocardial infarction.
PubMed 文献 · Eur Heart J · 2017-01-01

该前瞻性研究纳入1548例疑似心肌梗死患者,随访2年评估死亡率,其中99例最终诊断为2型心肌梗死(T2MI)。T2MI患者1年死亡率为13.8%,与1型心肌梗死(T1MI)患者的9.4%相当。基于女性、无放射至胸部疼痛及基线高敏肌钙蛋白I≤40.8 ng/L三个预测因子构建的评分(AUC 0.71)有助于区分T1MI与T2MI,最高分3分者T2MI概率为72%。

要点

  • T2MI患者1年死亡率13.8%,与T1MI的9.4%相近,提示高危。
  • 女性、无放射至胸痛、高敏肌钙蛋白I≤40.8 ng/L是T2MI最强预测因子。
  • 基于上述三因子的评分AUC 0.71,最高分3分时T2MI概率72%。

核心结论

  • T2MI患者为异质性高危人群,基于实验室和临床参数的评分可能有助于区分T1MI与T2MI。

研究设计与样本

  • 前瞻性纳入1548例疑似心肌梗死患者,随访至2年评估死亡率,采用向后逐步选择逻辑回归确定T2MI预测因子并构建诊断预测模型(评分)。

主要发现

  • 99例患者最终诊断为T2MI。
  • T2MI患者1年死亡率为13.8%,T1MI患者为9.4%。
  • 女性(Beta 1.27 [95%CI 0.67-1.90])、无放射至胸部疼痛(Beta 1.62 [CI 0.96-2.34])和高敏肌钙蛋白I≤40.8 ng/L(Beta 1.30 [CI 0.74-1.89])是T2MI最强预测因子。
  • 三个预测因子组合的AUC为0.71。
  • 二元评分每项预测因子计1分,最高分3分者T2MI概率为72%。

关键数值与推荐

  • T2MI预测评分:女性、无放射至胸部疼痛、基线高敏肌钙蛋白I≤40.8 ng/L各计1分。
  • 评分最高3分对应T2MI概率72%,模型AUC 0.71。

临床怎么用

  • 该评分基于实验室和临床参数,可能帮助急诊区分T1MI与T2MI患者。
  • 评分在临床常规中的额外应用需前瞻性研究验证。

局限性

  • 评分在临床常规中的附加应用需前瞻性研究调查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The differentiation of type 1 and type 2 myocardial infarction (T1MI, T2MI) is important, but challenging in the emergency department. We aimed to investigate the clinical characteristics and cardiovascular outcome of T2MI patients and to develop a clinical decision tool to differentiate T1MI and T2MI patients. METHODS AND RESULTS: We prospectively enrolled 1548 patients with suspected MI. All patients were followed for up to 2 years to assess mortality. We used logistic regression with backward step-down selection to determine the most important predictors of T2MI. Based on these regression coefficients, we developed a diagnostic prediction model (score) to diagnose T2MI. T2MI was the final diagnosis of 99 patients. Patients with T2MI showed a high 1-year mortality rate (13.8%), which equals that of T1MI patients (9.4%). Female sex (Beta 1.27 [95% confidence interval; CI 0.67-1.90]), not having radiating chest pain (Beta 1.62 [CI 0.96-2.34]) and a baseline high-sensitivity troponin I concentration ≤ 40.8 ng/L (Beta 1.30 [CI 0.74-1.89]) were the strongest predictors for T2MI. Their combination resulted in an area under the curve of 0.71 to discriminate T1MI and T2MI. The binary score based on this model assigns one point to each of the predictors. Patients with the highest score value of 3 had a 72% probability of T2MI. CONCLUSION: T2MI patients are a heterogeneous population with high-cardiovascular risk. A score based on laboratory and clinical parameters might help to differentiate T1MI and T2MI patients. The additional use of this score in clinical routine needs to be investigated prospectively. TRIAL REGISTRATION: www.clinicaltrials.gov (NCT02355457).

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Neumann JT, Sörensen NA, Rübsamen N, et al. Discrimination of patients with type 2 myocardial infarction. Eur Heart J. 2017. PMID: 29020401. doi:10.1093/eurheartj/ehx457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。